Peroxisome Proliferator-Activated Receptor-Gamma Agonist 4-O-Methylhonokiol Induces Apoptosis by Triggering the Intrinsic Apoptosis Pathway and Inhibiting the PI3K/Akt Survival Pathway in SiHa Human Cervical Cancer Cells
Peroxisome Proliferator-Activated Receptor-Gamma Agonist 4-O-Methylhonokiol Induces Apoptosis by Triggering the Intrinsic Apoptosis Pathway and Inhibiting the PI3K/Akt Survival Pathway in SiHa Human Cervical Cancer Cells
Journal of Microbiology and Biotechnology. 2015. Mar, 25(3): 334-342
Copyright © 2015, The Korean Society For Microbiology And Biotechnology
  • Received : November 28, 2014
  • Accepted : January 02, 2015
  • Published : March 28, 2015
Export by style
Cited by
About the Authors
Seungyeon, Hyun
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea
Man Sub, Kim
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea
Yong Seok, Song
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea
Yesol, Bak
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea
Sun Young, Ham
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea
Dong Hun, Lee
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea
Jintae, Hong
College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 361-463, Republic of Korea
Do Young, Yoon
Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul 143-701, Republic of Korea

4- O -Methylhonokiol (MH), a bioactive compound derived from Magnolia officinalis , is known to exhibit antitumor effects in various cancer cells. However, the precise mechanism of its anticancer activity in cervical cancer cells has not yet been studied. In this study, we demonstrated that MH induces apoptosis in SiHa cervical cancer cells by enhancing peroxisome proliferator-activated receptor-gamma (PPARγ) activation, followed by inhibition of the PI3K/Akt pathway and intrinsic pathway induction. MH upregulated PPARγ and PTEN expression levels while it decreased p-Akt in the MH-induced apoptotic process, thereby supporting the fact that MH is a PPARγ activator. Additionally, MH decreased the expression of Bcl-2 and Bcl-XL, inducing the intrinsic pathway in MH-treated SiHa cells. Furthermore, MH treatment led to the activation of caspase-3/caspase-9 and proteolytic cleavage of polyADP ribose polymerase. The expression levels of Fas (CD95) and E6/E7 oncogenes were not altered by MH treatment. Taken together, MH activates PPARγ/PTEN expression and induces apoptosis via suppression of the PI3K/Akt pathway and mitochondria-dependent pathways in SiHa cells. These findings suggest that MH has potential for development as a therapeutic agent for human cervical cancer.
The Magnolia bark derived from Magnolia officinalis has been used in traditional Chinese medicine [2] . Several bioactive compounds of the Magnolia bark, including 4- O -methylhonokiol, honokiol, and magnolol, exhibit many biological effects such as anti-inflammatory, antithrombocytic, anti-anxiety, antimicrobial, and anti-human immunodeficiency virus activities [1 , 14 , 17 , 21 , 27 , 37] . In particular, 4- O -methylhonokiol (MH)*, known as a peroxisome proliferatoractivated receptor (PPAR)-γ agonist, exhibits antitumor effects, including antiproliferative activity and induction of apoptosis in prostate and colon cancer cells [20 , 26] . Therefore, PPARγ agonists are regarded as a potential strategy for cancer chemoprevention and therapy [11 , 30] .
Peroxisome proliferator-activated receptors belonging to the nuclear hormone receptor superfamily are one of the ligand-dependent transcription factors that regulate glucose, lipid, and amino acid metabolism [28 , 30] . PPARs are classified into PPARα, PPAR β/δ, and PPARγ subtypes, which are encoded by different genes, and have common as well as distinctive activities [22] . PPARγ and its ligands especially play an important role in regulating tumor suppressive activities in many cancers [10 , 31 , 35] .
The PI3K/Akt signaling pathway is a major pathway in regulating cell survival signals [15] . Phosphatidylinositol-3 kinase (PI3K) is one of the members of the lipid kinase family. PI3K is involved in cell survival pathways, cell metabolism, and cytoskeletal rearrangements by phosphorylating the 3’-OH group of inositol to produce phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P 3 ) as a second messenger [4] . Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), known as an antagonist of PI3K, decreases activated PI3K signals by dephosphorylating PIP 3 [15] . Recent studies have demonstrated that decreased PTEN expression is related to the progressive feature of many cancers, including cervical cancers [13] . Akt is a main downstream target of PI3K, and activated Akt phosphorylates various downstream targets to regulate diverse cellular functions such as cell cycle progression, proliferation, cell survival, angiogenesis, tumor growth, and apoptosis [7 , 9 , 16] .
In this study, we investigated the anticancer effect of MH in SiHa human cervical cancer cells. MH has been reported to exhibit various biological effects, including antitumor effects. However, in cervical cancer cell lines, the precise antitumor mechanism of MH remains elusive. We demonstrate that MH exerts anticancer activity in SiHa cells through inhibition of the PI3K/Akt pathway and induction of the intrinsic pathway following PPARγ activation.
Materials and Methods
- Reagents
4- O -Methylhonokiol (MH) was generously supplied by Professor Heon Sang Jung (Department of Food Science, Chungbuk National University, Cheongju, Korea). DAPI staining solution and propidium iodide (PI) were obtained from Sigma (St. Louis, MO, USA). The Fluorescein isothiocyanate (FITC) annexin V Apoptosis Detection Kit I was purchased from BD Biosciences (San Diego, CA, USA). Antibodies specific to caspase-3, caspase-9, caspase-8, PTEN, polyADP ribose polymerase (PARP), Bax, Bcl-2, Bcl-XL, and α-mouse IgG horseradish-peroxidase (HRP)-conjugated secondary antibody were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies specific to GAPDH, PPARγ, Akt, p-Akt1/2/3, and anti-goat IgG HRP-conjugated secondary antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The anti-rabbit IgG HRP-conjugated secondary antibody was purchased from Assay Designs (Ann Arbor, MI, USA). JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl benzimidazolylcarbocyanine iodide) was purchased from Enzo (Farmingdale, NY, USA).
- Cell Culture
High-risk HPV-16 genotype SiHa cells were obtained from the American Type Culture Collection (ATCC; Rockville, MD, USA). The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and antibiotics (all of Hyclone Laboratories, UT, USA) and incubated at 37℃ with 5% CO 2 .
- Cell Viability Assays
Cell viability was observed trypan blue reagents. SiHa cells (3 × 10 5 cells/well) were seeded into a 6-well plate, incubated overnight, and then treated with various concentrations of MH (0, 10, 20, and 40 µM). After each well was washed using phosphate buffered saline (PBS), they were harvested using trypsinethylenediaminetetraacetic acid (EDTA), and then centrifuged at 100 × g for 5 min at 4℃. The supernatant was removed and the pellet was resuspended with PBS. After mixing the cell suspension with 0.4% trypan blue solution (1:1 (v/v)), the mixture was incubated for 2 min at room temperature. Stained (nonviable) and unstained (viable) cells were counted using a hematocytometer.
- Cell Morphology and DAPI Staining
Cell morphology was observed using an inverted phasecontrast microscope. Apoptotic nuclear morphological changes were detected by DAPI staining. Cells were cultured on coverslips and treated with MH. The coverslips were washed twice using serum-free DMEM and fixed with 100% acetone for 10 min at room temperature. After three washings with PBS, the fixed cells were stained with DAPI for 10 sec at 37℃, washed twice with PBS, and dried completely. After mounting on microscope slides, the stained cells were imaged using an Uplight fluorescence microscope (Olympus, Japan).
- Annexin V-FITC/PI Staining
SiHa cells (3 × 10 5 cells/well) were seeded into a 6-well plate, incubated overnight, and then treated with various concentrations of MH. After the MH-treated cells were incubated for 72 h, they were harvested and double stained with Annexin-FITC and PI (FITC Annexin V Apoptosis Detection Kit I) according to the manufacturer’s instructions. Stained cells were counted by flow cytometry on a FACSCalibur instrument (BD Biosciences), and the percentages of cells were calculated and analyzed by the CellQuest Pro software (BD Biosciences).
- Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
After RNA extraction using an easy-BLUE total RNA extraction kit (iNtRon Biotechnology, Seoul, Korea), the cDNA products were obtained using M-MuLV reverse transcriptase (New England Biolabs, Beverly, MA, USA). We performed RT-PCR analysis using a PCR thermal cycler Dice instrument (TaKaRa, Otsu, Shiga, Japan) with the following primer sets; E6: 5’-GCAGCCCTTGAATTACCCAT-3’ (forward), 5’-CAGAGGTTGGACAGGGAAGAA-3’ (reverse); E7: 5’-ATGCATGGAGATACACCTACATTGC-3’ (forward), 5’-TTATGGTTTCTGAGAACAGATGGGGC-3’ (reverse); Fas: 5’-TGAAGGACATGGCTTAGAAGTG-3’ (forward), 5’-GGTGCAAGGGTCACAGTGTT-3’ (reverse); FADD: 5’-ACCTCTTCTCCATGCTG-3’ (forward), 5’-CACACAGGTCTTCCCCA-3’ (reverse); DR5: 5’-GTCTGCTCTGATCACCCAAC-3’ (forward), 5’-CTGCAAACTGTGACTCCTATG-3’ (reverse); TRAIL: 5’-GTCTCTCTGTGTGGCTGTAA-3’ (forward), 5’-TGTTGCTTCTTCCTCTGGCT-3’ (reverse); and FasL: 5’-CAAGATTGACCCCGGAAGTA-3’ (forward), 5’-GGC CTGTGTCTCCTTGRGAT-3’ (reverse).
- Immunoblot Assay
The MH-treated cells were scraped from plates and centrifuged (72 × g , 3 min, 4℃). The pellets were washed with ice-cold PBS and centrifuged (1,890 × g , 5 min, 4℃). This process was repeated twice. The pellets were then lysed in a buffer (pH7.4) containing 1.5 M sodium chloride, 50 mM Tris, 1 mM EDTA, 0.1% sodium dodecyl sulfate (SDS), 0.25% sodium deoxycholate, 1% NP-40, and a protease inhibitor cocktail. Protein concentration was determined by using Bradford’s assay (Bio-Rad, Hercules, CA, USA). Samples were subjected to 10% and 12% SDS polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). Membranes were blocked with 5% nonfat dry milk dissolved in TBST (140 mM NaCl, 27 mM KCl, 10 mM Na 2 HPO 4 ·12H 2 O, 1.8 mM KH 2 PO 4 , and 0.05% Tween-20). Primary antibodies specific to caspase-3, caspase-9, caspase-8, PARP, Bax, Bcl-2, Bcl-XL, cytochrome C, PTEN, PPARγ, Akt, p-Akt 1/2/3, and GAPDH were adsorbed to the membranes. The adherent proteins were visualized using HRPconjugated secondary antibodies with the Westzol plus Western blot detection system (iNtRON Biotechnology).
- JC-1 Staining
To detect changes in the mitochondrial membrane potential, which is one of the most distinctive apoptotic features, we used the JC-1 dye. After MH-treated cells were harvested, they were stained with JC-1 at 37℃ in 5% CO 2 for 10 min. Stained cells were detected by flow cytometry in a FACSCalibur instrument and analyzed using CellQuest pro software (BD Biosciences). We also cultured SiHa cells on coverslips and treated with MH. MH-treated cells were stained with JC-1 at 37℃ in 5% CO 2 for 15 min, and the coverslips were washed twice using PBS. After mounting on microscope slides, the stained cells were imaged using the Uplight fluorescence microscope. JC-1 monomers in apoptotic cells were detected at 485 nm excitation/535 nm emission, and JC-1 aggregates in healthy cells were detected at 540 nm excitation/570 nm emission.
- Statistical Analysis
Data were presented as the mean ± SD values. Statistical analysis was assessed using Student’s t test with the following significance levels: * p < 0.05, ** p < 0.01.
- MH Induces Antiproliferation and Apoptosis in SiHa
We treated the SiHa cells with various concentrations of MH under incubation for 24, 48, and 72 h and measured the cytotoxicity using the trypan blue assay. The assay result indicated that a high concentration of MH (40 µM) was significantly cytotoxic after 72 h treatment, as shown in Fig. 1 . Therefore, we investigated the apoptotic effect of MH after 72 h treatment. We observed that MH induced morphological changes and a decrease of proliferation of cells ( Fig. 2 A). We investigated if these results are due to apoptosis. We could detect chromatin condensation by nuclear staining with DAPI dye ( Fig. 2 B). Cell numbers at the Sub-G1 phase were increased by MH, and this result described that nuclear fragmentation had occurred ( Fig. 2 C). Furthermore, in the AnnexinV-FITC/PI staining result, the proportion of cells moved to the upper-right quadrant ( Fig. 2 D). There was a significant increased level of Annexin V-FITC/PI positive cells in 40 µM MH-treated cells ( Fig. 2 E). Together, these results suggest that a high concentration of MH promotes cell death through the induction of apoptosis.
PPT Slide
Lager Image
Cytotoxic effects of MH in SiHa. SiHa cells were treated with various concentrations of MH (0, 10, 20, and 40 µM) for 24, 48, and 72 h, and the cell viability was assessed by trypan blue reagent as described in the Methods section. The viability of untreated cells was set at 100%. All data represent the mean ± SD of three experiments performed in triplicate.
PPT Slide
Lager Image
Antiproliferative and apoptotic effects of MH in SiHa. (A) Cells were treated with different concentrations of MH for 72 h and observed under a phase-contrast microscope (400×). (B) Nuclear morphological change was detected using DAPI staining and fluorescence microscopy (200×). (C) Sub-G1 accumulation of PI-stained SiHa cells was analyzed by flow cytometry. The data represent the mean ± SD of three experiments conducted in triplicate. *p < 0.05 compared with untreated control cells. (D) Apoptosis of SiHa cells treated with MH was detected by AnnexinV-FITC/PI staining and analyzed by flow cytometry. The data represent one of three independent experiments. (E) AnnexinV-FITC/PI data presented as bar graphs with the mean ± SD of three independent experiments. *p < 0.05, compared with untreated control cells.
- MH Reduces the Survival of SiHa Through Suppression of the PI3K/Akt Survival Signaling Pathway
PPARγ agonists exhibit antitumor activities through PPARγ dependent or independent effects [12 , 38] . We confirmed that PPARγ expression was increased by MH ( Fig. 3 A). According to recent reports, PTEN, which is one of the PPARγ target genes, is involved in the PI3K/Akt survival pathway by inducing Akt dephosphorylation [36] . Therefore, we identified the expression levels of PTEN, Akt, and p-Akt by using immunoblot assay. The PTEN expression was increased, but its downstream factor p-Akt was reduced by MH ( Fig. 3 A). To confirm whether PPARγ is involved in the PI3K/Akt pathway, we pretreated cells with the PPARγ antagonist GW9662 for 1 h before MH treatment. Interestingly, MH-induced PTEN expression was reduced, and Akt phosphorylation was recovered by GW9662 ( Fig. 3 B). However, GW9662 itself did not affect MH-induced PPARγ expression ( Fig. 3 B). Therefore, these results demonstrate that the effects of MH are dependent on PPARγ, and MH inhibits the PI3K/Akt pathway.
PPT Slide
Lager Image
Effects of MH on PPARγ expression and regulation of the PI3K/Akt survival signaling pathway. SiHa cells were treated with various concentrations of MH for 72 h. (A) The expression levels of PPARγ, PTEN, Akt, and p-Akt were detected by immunoblot assay. (B) After SiHa cells were pre-treated with the PPARγ antagonist GW9662 (5 µM) for 1 h, cells were treated with MH (40 µM) for 72 h. The expression levels of PPARγ, PTEN, Akt, and p-Akt were detected by immunoblot assay. GAPDH was used as the internal control.
- MH Induces Apoptosis Through the Caspase Cascade
Cysteine-dependent aspartate-directed proteases (caspases) play critical roles in inducing apoptosis [24] . Processing PARP, a downstream factor of caspases, is a pivotal indicator of apoptosis [24] . As shown in Fig. 4 , caspase-9 and caspase-3 were cleaved while caspase-8 levels were not altered, and cleavaged forms were not detected. The processing of PARP occurred in the presence of a high concentration of MH. Taken together, MH induces apoptosis through a caspase-mediated pathway.
PPT Slide
Lager Image
Effects of MH on the processing of caspase cascade factors in SiHa. Cells were treated with different concentrations of MH for 72 h. Processing of PARP, caspase-9, caspase-3, and caspase-8 was detected by immunoblot assay. GAPDH was used as an internal control.
- MH Induces Apoptosis Through Intrinsic Pathways
Apoptosis can be induced through two pathways, intrinsic and extrinsic [32] . First, we confirmed that the MH induced the mitochondria-dependent apoptosis pathway. In the intrinsic pathway, the balance between pro-apoptotic and anti-apoptotic Bcl-2 family proteins is broken, and mitochondrial outer membrane permeabilization (MOMP) occurs, which consequently triggers apoptosis [33] . Therefore, the Bcl-2 family plays a significant role in the intrinsic pathway. To detect the expression levels of anti-apoptotic (Bcl-2 and Bcl-XL) and pro-apoptotic (Bax) factors of the Bcl-2 family, we performed immunoblot assays. MH treatment induced a reduction of Bcl-2 and Bcl-XL expression in a dose-dependent manner ( Fig. 5 A). The expression of Bax was not changed by MH.
PPT Slide
Lager Image
Effects of MH on the expression of apoptosis-related factors involved in the intrinsic pathway in SiHa. (A) Expression levels of Bcl-XL, Bcl-2, and Bax were detected by immunoblot assay. (B) Mitochondrial membrane potential collapse was induced by MH. (C) Cytochrome C release was detected by immunoblot assay. GAPDH was used as an internal control.
MOMP is essential to cytochrome C release [33] . Released cytochrome C triggers executor caspase activation [33] . For that reason, we examined the mitochondrial membrane potential collapse and cytochrome C release. We first performed JC-1 staining. As can be seen in Fig. 5 B, the peaks were shifted to the left. This result means that mitochondrial potential loss was triggered at high concentration of MH compared with control. Furthermore, as shown in Fig. 5 C, cytochrome C release into the cytosol was enhanced at a high dose of MH. Therefore, these data suggest that MH induces apoptosis by passing through the mitochondria.
- MH-Induced Apoptosis Is Independent of Extrinsic Pathways and HPV E6/E7 Viral Oncogenes
The death receptor-dependent pathway also plays a role in inducing the apoptotic process [39] . Accordingly, we investigated whether the extrinsic pathway is involved in MH-mediated apoptosis. The Fas/FasL and DR5/TRAIL expression levels were not significantly altered after MH treatment ( Fig. 6 A). FADD and caspase-8 expression was also independent of MH treatment ( Figs. 6 A and 4). Expression of E6/E7 oncogenes is a feature of HPV-positive cervical cancer cells [18] . For this reason, to investigate whether MH has an inhibitory effect on E6 and E7 expression in SiHa, we analyzed the transcription levels of E6 and E7 by RT-PCR analysis. Interestingly, MH did not downregulate both E6 and E7 transcripts ( Fig. 6 B), suggesting that MH-induced apoptosis is independent of the extrinsic pathway and E6/E7 oncogenes in SiHa cells.
PPT Slide
Lager Image
Effects of MH on the expression of death rerecptors and their related factors involved in the extrinsic pathway and E6/E7 expression in SiHa. SiHa cells were treated with various concentrations of MH for 72 h. (A) Transcriptional levels of Fas, FasL, DR5, TRAIL, and FADD were determined by RT-PCR. (B) E6 and E7 mRNA levels were measured by RT-PCR. These levels were normalized to the GAPDH mRNA level and presented as bar graphs.
Recently, 4- O -methylhonokiol has been known as a new PPARγ agonist, and it inhibits growth of several cancer cells [20 , 26] . MH enhances not only the PPARγ expression level but also the transcriptional activity [20] . Activated PPARγ regulates the transcription of diverse genes [19 , 36] . Of these, PTEN is involved in the PI3K/Akt pathway [15] . PTEN acts as a phosphatase of PIP 3 , resulting in the dephosphorylation of Akt [15] . Akt regulates various cellular functions, including apoptosis, by inducing phosphorylation of downstream targets [7 , 9 , 16] . In the present data, MH clearly influenced the PI3K/Akt pathway by blocking it ( Fig. 3 ) and induced apoptosis in SiHa.
Apoptosis plays essential roles in cell survival, growth, development, and tumorigenesis, and it is mediated by two mechanisms [34] . The intrinsic pathway plays a crucial role in triggering apoptosis, and an imbalance between the Bcl-2 family leads to this pathway [6] . It has been demonstrated that Bad is one of the target genes of Akt [8] . When p-Akt is reduced, Bad phosphorylation is inhibited [8] . Unphosphorylated Bad forms a heterodimer with Bcl-XL or Bcl-2 and blocks their anti-apoptotic activity [8] . It triggers an imbalance between the Bcl-2 family, which forms a pore in the mitochondrial outer membrane. Cytochrome C is released from the mitochondrial intermembrane space [6 , 23] . As a result, the caspase cascade is induced, and it stimulates PARP cleavage, which is a pivotal indicator in apoptosis initiation [25] . Our results indicated that MH destroyed the balance of the Bcl-2 family and consequently triggered caspase-9/-3 activation. However, death receptors and cognate ligands were not altered, and also caspase-8 was not activated. Taken together, it seems that MH induced the intrinsic apoptosis pathway by inhibiting Akt phosphorylation.
Cervical cancer is the second leading gynecological carcinoma in women worldwide [5] . Infection with human papillomavirus (HPV) causes most cervical cancers. HPV types have been classified into low-risk or high-risk types, both of which are frequently found in most cervical cancers [3] . The viral E6 and E7 oncogenes contribute to the development of HPV-infected cervical cancer [18] . Accordingly, much of the research regarding cervical cancer has focused on HPV-positive types.
However, in the present study, MH exerted a strong anticancer effect on SiHa harboring HPV without influencing the E6/E7 oncogenes. Recent studies demonstrate that the PI3K/Akt pathway is considerably activated, and it is associated with regulating the tumor metabolic response in cervical cancers in vitro and in vivo . Increased p-Akt level is related to enhanced glucose uptake in those cells [29] . Therefore, the PI3K/Akt pathway is a therapeutic target in cervical carcinoma [29] . Our data clearly indicate that MH decreased the expression of members of the PI3K/Akt pathway in SiHa ( Fig. 3 ). These findings suggest that MH has potential as an antitumor agent in cervical cancer.
In summary, we report, for the first time, that the new PPARγ agonist MH induces apoptosis via inhibition of the PI3K/Akt survival pathway, activating the intrinsic pathway in the SiHa cervical carcinoma cell line ( Fig. 7 ). Therefore, our results demonstrate that MH can be used as an anticancer agent for human cervical cancer.
PPT Slide
Lager Image
Molecular mechanisms underlying 4-O-methylhonokiol (MH)-induced apoptosis in SiHa cervical cancer cells. MH activates PPARγ, and the PTEN expression level is enhanced. Phosphorylation of Akt is decreased by PTEN, thereby resulting in repression of the PI3K/Akt survival pathway. A balance between the Bcl-2 family collapses, and mitochondrial outer membrane permeabilization occurs. As a result, cytochrome C is released, and caspases are cleaved and activated. Taken together, MH induces apoptosis by inhibiting the PI3K/Akt pathway and triggering the intrinsic apoptosis pathway.
This work was supported by the Ministry of Health, Welfare, and Family Affairs, Korea (A120833).
Amblard F , Delinsky D , Arbiser JL , Schinazi RF 2006 Facile purification of honokiol and its antiviral and cytotoxic properties. J. Med. Chem. 49 3426 - 3427    DOI : 10.1021/jm060268m
Arora S , Singh S , Piazza GA , Contreras CM , Panyam J , Singh AP 2012 Honokiol: a novel natural agent for cancer prevention and therapy. Curr. Mol. Med. 12 1244 - 1252    DOI : 10.2174/156652412803833508
Bosch FX , Lorincz A , Munoz N , Meijer CJ , Shah KV 2002 The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 244 - 265    DOI : 10.1136/jcp.55.4.244
Cantley LC 2002 The phosphoinositide 3-kinase pathway. Science 296 1655 - 1657    DOI : 10.1126/science.296.5573.1655
Chen L , Liu Q , Qin R , Le H , Xia R , Li W , Kumar M 2005 Amplification and functional characterization of MUC1 promoter and gene-virotherapyviaa targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cellsin vitro. Int.J. Mol. Med. 15 617 - 626
Chipuk JE , Green DR 2008 How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18 157 - 164    DOI : 10.1016/j.tcb.2008.01.007
Datta SR , Brunet A , Greenberg ME 1999 Cellular survival: a play in three Akts. Genes Dev. 13 2905 - 2927    DOI : 10.1101/gad.13.22.2905
Datta SR , Dudek H , Tao X , Masters S , Fu H , Gotoh Y , Greenberg ME 1997 Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 231 - 241    DOI : 10.1016/S0092-8674(00)80405-5
Duronio V , Scheid MP , Ettinger S 1998 Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cell Signal. 10 233 - 239    DOI : 10.1016/S0898-6568(97)00129-0
Eibl G , Wente MN , Reber HA , Hines OJ 2001 Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem. Biophys. Res. Commun. 287 522 - 529    DOI : 10.1006/bbrc.2001.5619
Elrod HA , Sun SY 2008 PPARgamma and apoptosis in cancer. PPAR Res. 2008 704165 -    DOI : 10.1155/2008/704165
Fujita M , Tohji C , Honda Y , Yamamoto Y , Nakamura T , Yagami T 2012 Cytotoxicity of 15-deoxy-delta(12,14)-prostaglandin J(2) through PPARgamma-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma. Int. J. Med. Sci. 9 555 - 566    DOI : 10.7150/ijms.4455
Harima Y , Sawada S , Nagata K , Sougawa M , Ostapenko V , Ohnishi T 2001 Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int. J. Oncol. 18 493 - 497
Hu H , Zhang XX , Wang YY , Chen SZ 2005 Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol. Sin. 26 1063 - 1068    DOI : 10.1111/j.1745-7254.2005.00164.x
Jiang BH , Liu LZ 2008 PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim. Biophys. Acta 1784 150 - 158    DOI : 10.1016/j.bbapap.2007.09.008
Jiang BH , Zheng JZ , Aoki M , Vogt PK 2000 Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97 1749 - 1753    DOI : 10.1073/pnas.040560897
Kang JS , Lee KH , Han MH , Lee H , Ahn JM , Han SB 2008 Antiinflammatory activity of methanol extract isolated from stem bark ofMagnolia kobus. Phytother. Res. 22 883 - 888    DOI : 10.1002/ptr.2386
Klaes R , Woerner SM , Ridder R , Wentzensen N , Duerst M , Schneider A 1999 Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59 6132 - 6136
Kliewer SA , Umesono K , Noonan DJ , Heyman RA , Evans RM 1992 Convergence of 9-cisretinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 771 - 774    DOI : 10.1038/358771a0
Lee NJ , Oh JH , Ban JO , Shim JH , Lee HP , Jung JK 2013 4-O-Methylhonokiol, a PPARgamma agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-kappaB activity. Br. J. Pharmacol. 168 1133 - 1145    DOI : 10.1111/j.1476-5381.2012.02235.x
Lee YJ , Lee YM , Lee CK , Jung JK , Han SB , Hong JT 2011 Therapeutic applications of compounds in theMagnoliafamily. Pharmacol. Ther. 130 157 - 176    DOI : 10.1016/j.pharmthera.2011.01.010
Lehrke M , Lazar MA 2005 The many faces of PPARgamma. Cell 123 993 - 999    DOI : 10.1016/j.cell.2005.11.026
Li P , Nijhawan D , Budihardjo I , Srinivasula SM , Ahmad M , Alnemri ES , Wang X 1997 Cytochromecand dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 479 - 489    DOI : 10.1016/S0092-8674(00)80434-1
Lowe SW , Cepero E , Evan G 2004 Intrinsic tumour suppression. Nature 432 307 - 315    DOI : 10.1038/nature03098
Martin MC , Allan LA , Lickrish M , Sampson C , Morrice N , Clarke PR 2005 Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochromec. J. Biol. Chem. 280 15449 - 15455    DOI : 10.1074/jbc.M414325200
Oh JH , Ban JO , Cho MC , Jo M , Jung JK , Ahn B 2012 4-O-Methylhonokiol inhibits colon tumor growthviap21-mediated suppression of NF-kappaB activity. J. Nutr. Biochem. 23 706 - 715    DOI : 10.1016/j.jnutbio.2011.03.013
Park J , Lee J , Jung E , Park Y , Kim K , Park B 2004 In vitroantibacterial and anti-inflammatory effects of honokiol and magnolol againstPropionibacteriumsp. Eur. J. Pharmacol. 496 189 - 195    DOI : 10.1016/j.ejphar.2004.05.047
Rocchi S , Auwerx J 1999 Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Ann. Med. 31 342 - 351    DOI : 10.3109/07853899908995901
Schwarz JK , Payton JE , Rashmi R , Xiang T , Jia Y , Huettner P 2012 Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clin. Cancer Res. 18 1464 - 1471    DOI : 10.1158/1078-0432.CCR-11-2485
Sertznig P , Seifert M , Tilgen W , Reichrath J 2007 Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. J. Cell. Physiol. 212 1 - 12    DOI : 10.1002/jcp.20998
Shimada T , Kojima K , Yoshiura K , Hiraishi H , Terano A 2002 Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. Gut 50 658 - 664    DOI : 10.1136/gut.50.5.658
Susin SA , Daugas E , Ravagnan L , Samejima K , Zamzami N , Loeffler M 2000 Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192 571 - 580    DOI : 10.1084/jem.192.4.571
Tait SW , Green DR 2010 Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11 621 - 632    DOI : 10.1038/nrm2952
Tan ML , Ooi JP , Ismail N , Moad AI , Muhammad TS 2009 Programmed cell death pathways and current antitumor targets. Pharm. Res. 26 1547 - 1560    DOI : 10.1007/s11095-009-9895-1
Tsubouchi Y , Sano H , Kawahito Y , Mukai S , Yamada R , Kohno M 2000 Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptorgamma agonists through induction of apoptosis. Biochem. Biophys. Res. Commun. 270 400 - 405    DOI : 10.1006/bbrc.2000.2436
Voutsadakis IA 2007 Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis. J. Cancer Res. Clin. Oncol. 133 917 - 928    DOI : 10.1007/s00432-007-0277-y
Weeks BS 2009 Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med. Sci. Monit. 15 RA256 - RA262
Woo CC , Loo SY , Gee V , Yap CW , Sethi G , Kumar AP , Tan KH 2011 Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-gamma pathway. Biochem. Pharmacol. 82 464 - 475    DOI : 10.1016/j.bcp.2011.05.030
Zimmermann KC , Bonzon C , Green DR 2001 The machinery of programmed cell death. Pharmacol. Ther. 92 57 - 70    DOI : 10.1016/S0163-7258(01)00159-0